ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of SGN-30 (Anti-CD30 mAb) in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00099255
Recruitment Status : Completed
First Posted : December 10, 2004
Last Update Posted : December 18, 2014
Sponsor:
Information provided by:
Seattle Genetics, Inc.